These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 20139986)

  • 1. Chromogranin A is an autoantigen in type 1 diabetes.
    Stadinski BD; Delong T; Reisdorph N; Reisdorph R; Powell RL; Armstrong M; Piganelli JD; Barbour G; Bradley B; Crawford F; Marrack P; Mahata SK; Kappler JW; Haskins K
    Nat Immunol; 2010 Mar; 11(3):225-31. PubMed ID: 20139986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal additions to the WE14 peptide of chromogranin A create strong autoantigen agonists in type 1 diabetes.
    Jin N; Wang Y; Crawford F; White J; Marrack P; Dai S; Kappler JW
    Proc Natl Acad Sci U S A; 2015 Oct; 112(43):13318-23. PubMed ID: 26453556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasostatin-1 antigenic epitope mapping for induction of cellular and humoral immune responses to chromogranin A autoantigen in NOD mice.
    Nikoopour E; Cheung R; Bellemore S; Krougly O; Lee-Chan E; Stridsberg M; Singh B
    Eur J Immunol; 2014 Apr; 44(4):1170-80. PubMed ID: 24443235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of autoreactive CD8+ T cell responses targeting chromogranin A in humanized NOD mice and type 1 diabetes patients.
    Li Y; Zhou L; Li Y; Zhang J; Guo B; Meng G; Chen X; Zheng Q; Zhang L; Zhang M; Wang L
    Clin Immunol; 2015 Jul; 159(1):63-71. PubMed ID: 25958206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromogranin A is a T cell antigen in human type 1 diabetes.
    Gottlieb PA; Delong T; Baker RL; Fitzgerald-Miller L; Wagner R; Cook G; Rewers MR; Michels A; Haskins K
    J Autoimmun; 2014 May; 50():38-41. PubMed ID: 24239002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting edge: vasostatin-1-derived peptide ChgA29-42 is an antigenic epitope of diabetogenic BDC2.5 T cells in nonobese diabetic mice.
    Nikoopour E; Sandrock C; Huszarik K; Krougly O; Lee-Chan E; Masteller EL; Bluestone JA; Singh B
    J Immunol; 2011 Apr; 186(7):3831-5. PubMed ID: 21357258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting Edge: Nonobese Diabetic Mice Deficient in Chromogranin A Are Protected from Autoimmune Diabetes.
    Baker RL; Bradley B; Wiles TA; Lindsay RS; Barbour G; Delong T; Friedman RS; Haskins K
    J Immunol; 2016 Jan; 196(1):39-43. PubMed ID: 26608914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
    Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
    J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
    Mukherjee R; Wagar D; Stephens TA; Lee-Chan E; Singh B
    J Immunol; 2005 May; 174(9):5306-15. PubMed ID: 15843527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes.
    Kelemen K; Gottlieb PA; Putnam AL; Davidson HW; Wegmann DR; Hutton JC
    J Immunol; 2004 Mar; 172(6):3955-62. PubMed ID: 15004204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of Multiple Hybrid Insulin Peptides by a Single Highly Diabetogenic T-Cell Receptor.
    Parras D; Solé P; Delong T; Santamaría P; Serra P
    Front Immunol; 2021; 12():737428. PubMed ID: 34527002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Hybrid Insulin Epitope Maintains High 2D Affinity for Diabetogenic T Cells in the Periphery.
    Liu B; Hood JD; Kolawole EM; Woodruff DM; Vignali DA; Bettini M; Evavold BD
    Diabetes; 2020 Mar; 69(3):381-391. PubMed ID: 31806623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How C-terminal additions to insulin B-chain fragments create superagonists for T cells in mouse and human type 1 diabetes.
    Wang Y; Sosinowski T; Novikov A; Crawford F; White J; Jin N; Liu Z; Zou J; Neau D; Davidson HW; Nakayama M; Kwok WW; Gapin L; Marrack P; Kappler JW; Dai S
    Sci Immunol; 2019 Apr; 4(34):. PubMed ID: 30952805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetogenic T-cell clones recognize an altered peptide of chromogranin A.
    Delong T; Baker RL; He J; Barbour G; Bradley B; Haskins K
    Diabetes; 2012 Dec; 61(12):3239-46. PubMed ID: 22912420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse.
    Crawford F; Stadinski B; Jin N; Michels A; Nakayama M; Pratt P; Marrack P; Eisenbarth G; Kappler JW
    Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16729-34. PubMed ID: 21949373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin as a key autoantigen in the development of type 1 diabetes.
    Nakayama M
    Diabetes Metab Res Rev; 2011 Nov; 27(8):773-7. PubMed ID: 22069258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mimovirus encoding ChgA
    Sun H; Han X; Yan X; Xu J; Huang Q; Meng F; Zhang H; Li S
    Cell Immunol; 2017 Oct; 320():56-61. PubMed ID: 28916112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
    Chen C; Lee WH; Yun P; Snow P; Liu CP
    J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
    Serreze DV; Marron MP; Dilorenzo TP
    Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide dose, MHC affinity, and target self-antigen expression are critical for effective immunotherapy of nonobese diabetic mouse prediabetes.
    Winer S; Gunaratnam L; Astsatourov I; Cheung RK; Kubiak V; Karges W; Hammond-McKibben D; Gaedigk R; Graziano D; Trucco M; Becker DJ; Dosch HM
    J Immunol; 2000 Oct; 165(7):4086-94. PubMed ID: 11034420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.